A

Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR

International Journal of Molecular Sciences, vol. 24, pp. 13127

Abstract

The RNA-binding protein human antigen R (HuR) regulates stability, translation, and nucleus-to-cytoplasm shuttling of its target mRNAs. This protein has been progressively recognized as a relevant therapeutic target for several pathologies, like cancer, neurodegeneration, as well as inflammation. Inhibitors of mRNA binding to HuR might thus be beneficial against a variety of diseases. Here, we present the rational identification of structurally novel HuR inhibitors. In particular, by combining chemoinformatic approaches, high-throughput virtual screening, and RNA-protein pulldown assays, we demonstrate that the 4-(2-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)hydrazineyl)benzoate ligand exhibits a dose-dependent HuR inhibition effect in binding experiments. Importantly, the chemical scaffold is new with respect to the currently known HuR inhibitors, opening up a new avenue for the design of pharmaceutical agents targeting this important protein.

Authors 8

  1. RWTH Aachen University · Forschungszentrum Jülich

    Affiliation as printed

    Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany

    Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany

  2. RWTH Aachen University · Forschungszentrum Jülich

    Affiliation as printed

    Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany

    Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany

  3. University of Siegen

    Affiliation as printed

    Institute of Biology, University of Siegen, 57076 Siegen, Germany

  4. Forschungszentrum Jülich · University of Verona

    Affiliation as printed

    Department of Biotechnology, University of Verona, 37134 Verona, Italy

    Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany

  5. Forschungszentrum Jülich

    Affiliation as printed

    Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany

  6. Sybille Krauß corresponding

    University of Siegen

    Affiliation as printed

    Institute of Biology, University of Siegen, 57076 Siegen, Germany

  7. RWTH Aachen University · Forschungszentrum Jülich

    Affiliation as printed

    Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany

    Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany

  8. RWTH Aachen University · Forschungszentrum Jülich · Jülich Supercomputing Centre

    Affiliation as printed

    Department of Neurology, RWTH Aachen University, 44517 Aachen, Germany

    Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany

    Jülich Supercomputing Centre (JSC), Forschungszentrum Jülich, 52425 Jülich, Germany

Cited by 10 stored of 10

10 results

No patents citing this paper on Lens.org (checked 2026-10-06).

References 75